🔗 Share this article

The top legal official in Texas Paxton is taking legal action against the makers of acetaminophen, asserting the firms concealed alleged dangers that the pain reliever posed to children's cognitive development.

The lawsuit comes a month after Former President Trump advocated an unverified association between using acetaminophen - also known as acetaminophen - during pregnancy and autism spectrum disorder in young ones.

The attorney general is suing J&J, which formerly manufactured the drug, the only pain reliever approved for expectant mothers, and the current manufacturer, which presently makes it.

In a official comment, he claimed they "deceived the public by gaining financially from suffering and pushing pills ignoring the potential hazards."

Kenvue asserts there is insufficient reliable data linking Tylenol to autism spectrum disorder.

"These companies misled for generations, deliberately risking countless individuals to boost earnings," the attorney general, a Republican, stated.

Kenvue said in a statement that it was "seriously troubled by the spread of false claims on the safety of paracetamol and the potential impact that could have on the welfare of American women and children."

On its official site, the company also mentioned it had "consistently assessed the pertinent research and there is lacking reliable evidence that shows a proven link between using paracetamol and autism spectrum disorder."

Organizations representing physicians and healthcare providers concur.

The leading OB-GYN organization has said acetaminophen - the primary component in Tylenol - is a restricted selection for expectant mothers to treat pain and fever, which can present serious health risks if left untreated.

"In over twenty years of studies on the use of paracetamol in gestation, no reliable research has definitively established that the use of acetaminophen in any trimester of gestation causes neurological conditions in children," the association commented.

The court filing cites latest statements from the previous government in asserting the drug is reportedly hazardous.

Recently, Trump generated worry from medical authorities when he instructed expectant mothers to "resist strongly" not to consume acetaminophen when ill.

Federal regulators then published an announcement that physicians should think about restricting the use of acetaminophen, while also mentioning that "a proven link" between the medication and autism spectrum disorder in minors has remains unverified.

The Health Department head Kennedy, who oversees the FDA, had pledged in April to undertake "comprehensive study program" that would determine the source of autism spectrum disorder in a matter of months.

But authorities cautioned that identifying a unique factor of autism spectrum disorder - believed by scientists to be the result of a complicated interplay of genetic and environmental factors - would be difficult.

Autism is a form of permanent neurological difference and impairment that impacts how persons encounter and engage with the world, and is diagnosed using physician assessments.

In his lawsuit, the attorney general - who supports Trump who is running for the Senate - claims the manufacturer and Johnson & Johnson "deliberately disregarded and sought to suppress the evidence" around paracetamol and autism.

The lawsuit seeks to make the firms "eliminate any promotional materials" that states acetaminophen is safe for women during pregnancy.

The Texas lawsuit parallels the concerns of a collection of mothers and fathers of minors with autism spectrum disorder and attention deficit hyperactivity disorder who took legal action against the manufacturers of acetaminophen in recently.

Judicial authorities threw out the legal action, saying investigations from the family's specialists was inconclusive.